ClinicalTrials.Veeva

Menu

Pathway to Diagnosis of Ovarian Cancer (MITO-12)

N

National Cancer Institute, Naples

Status

Active, not recruiting

Conditions

Ovarian Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT01061619
MITO 12

Details and patient eligibility

About

The purpose of this study is to describe the prediagnostic symptoms and the events along the pathway to diagnosis of women with ovarian cancer, referred for first-line chemotherapy.

Enrollment

400 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histological diagnosis of ovarian cancer
  • Indication for chemotherapy
  • Age > 18 years
  • Signed informed consent

Exclusion criteria

  • Previous chemotherapy
  • Unable or unwilling to participate in interview

Trial contacts and locations

30

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems